Navigation Links
Orexigen(R) Therapeutics Announces Fourth Quarter and Year Ended December 31, 2009 Financial Results
Date:3/9/2010

"Orexigen has made significant progress in the past year that positions us for our transformation to a commercial enterprise," said Michael Narachi, President and CEO of Orexigen.  "We completed our Contrave Phase 3 Program and our Empatic Phase 2 program, both with very positive results, and have nearly completed all sections of our New Drug Application for Contrave, which we expect to file with the FDA by the end of April.  In addition, we raised additional capital which has allowed us to advance our preparations for a targeted commercial launch, and to outline the value proposition for potential partners that would enable access to the broader primary care markets."

2009 Highlights

  • Orexigen made a number of key additions to its management team and staff, which will help position the Company for long term regulatory and commercial success.  In April, Orexigen announced that it appointed Michael Narachi, a 20 year veteran of Amgen, as President and Chief Executive Officer.  Later in the year, the Company announced a number of other strategic hires:  Jay Hagan as Head of Corporate Development and Strategy, Mark Booth as Chief Commercial Officer, Dawn Viveash M.D. as Head of Global Regulatory Affairs, Suzanne McDonald as Head of Managed Markets a
    '/>"/>

SOURCE Orexigen Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. Orexigen(R) Initiates Second Phase IIb Empatic(TM) Trial on Schedule
2. Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R)
3. Orexigen(R) Therapeutics Announces Changes to Its Clinical Programs and Management Team
4. Orexigen(R) Therapeutics Schedules July 20, 2009 Teleconference and Webcast Discussion of Contrave(R) Phase 3 Results
5. Orexigen(R) Therapeutics Schedules September 30, 2009 Teleconference and Webcast to Discuss Phase 2b Trial Results From Second Obesity Drug Candidate, Empatic(TM)
6. Orexigen(R) Therapeutics Releases New Efficacy Data for Contrave(R) in Late Breaker Presentations at the 27th Annual Scientific Meeting of The Obesity Society
7. Orexigen(R) Therapeutics Announces Third Quarter 2009 Financial Results
8. Orexigen(R) Therapeutics to Speak at Lazard Capital Markets Healthcare Conference
9. Orexigen(R) Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635
10. Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
11. Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... Sept. 2, 2015 Research and Markets ... the "An Introduction to Medical Device Software: ... 2015)" conference to their offering. ... to the regulations and requirements that apply to ... interactive, using real life examples and state-of- the-art ...
(Date:9/2/2015)...  Research and Markets ( http://www.researchandmarkets.com/research/rf2c5p/an_introduction ) has ... to the Medical Devices Directive (London, UK - ... This seminar provides a detailed ... will explain the Directives and which products are ... choose one and outline what a manufacturer must ...
(Date:9/2/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/6x789c/new_eu ) has announced ... (London, UK - November 16-17, 2015)" conference to ... modules concerning Pharmacovigilance are a major departure in terms ... Europe . The intention of the course is ... how they overlap and fit together and what Companies ...
Breaking Medicine Technology:An Introduction to Medical Device Software: Regulations and Requirements Course - London, UK - November 2-3, 2015 2
(Date:9/3/2015)... , ... September 03, 2015 , ... Dr. Robert Winchell ... Trauma, Burns, Critical and Acute Care at NewYork-Presbyterian/Weill Cornell Medical Center, effective July 27. ... is a nationally renowned expert in care for the critically injured and the development, ...
(Date:9/3/2015)... ... 2015 , ... DiabetesSisters Welcomes Carol Wysham to Board of ... Carol Wysham, MD, to their esteemed Board of Directors. Dr. Wysham was elected ... Matt Stella, Tricia Cedotal, Andrea Thomas, Wanda Nicholson and Vicki Norris. As a ...
(Date:9/3/2015)... Ridgewood, NJ (PRWEB) , ... September 03, 2015 , ... A scar is an unavoidable ... is a near-miraculous example of the body's ability to heal itself. The appearance of a ... well as the individual's age, genes, and skin pigmentation. ”Many scars fade to near invisibility ...
(Date:9/3/2015)... ... September 03, 2015 , ... The ... Clinicians Report of Provo, Utah. The Clinicians Report is a leading information source ... dentists located throughout the U.S. Whiter Image's In-Office whitening kits were favorably validated ...
(Date:9/3/2015)... , ... September 03, 2015 , ... James Earl Jones ... workplace wellness. In this episode, James Earl Jones will introduce a segment that discusses ... unhealthy workplace and how workplace wellness can be fostered in any working environment. , ...
Breaking Medicine News(10 mins):Health News:Trauma Expert Joins NewYork-Presbyterian Hospital and Weill Cornell Medical College 2Health News:Trauma Expert Joins NewYork-Presbyterian Hospital and Weill Cornell Medical College 3Health News:Trauma Expert Joins NewYork-Presbyterian Hospital and Weill Cornell Medical College 4Health News:Trauma Expert Joins NewYork-Presbyterian Hospital and Weill Cornell Medical College 5Health News:Carol H. Wysham, MD, Joins DiabetesSisters Board of Directors 2Health News:Do I Have To Live With That Scar? 2Health News:Do I Have To Live With That Scar? 3Health News:Do I Have To Live With That Scar? 4Health News:Whiter Image Products Get Positive Rating From The Clinicians Report 2Health News:James Earl Jones Hosts a New "Voices In America" Piece on Making the Workplace Healthier 2
... Health Care Agency has confirmed that eating some live raw sawagani ... a lung fluke parasite infection that occurred in eight people.// ... or any of them -- ate them on a dare,' Thompson ... confirmed as being infected, but the number has risen to eight ...
... Duma has been named as one of the world's ... ,Technology Review nominated Duma, an associate professor of ... Forest Center for Injury Biomechanics, to the 2006 'TR35' ... of 35. ,The editors of Technology Review, ...
... Recent studies have shown that when one is out in ... 2 hours, else it would be better not using any ... Hanson, a chemist at the University of California at Riverside. ... the lab to UV radiation while they were covered with ...
... hands with Florida-based Roskamp Institute to conduct a study ... use in Alzheimer's disease. // ,The Dublin ... Age Psychiatry from St James’ Hospital, Beaumont Hospital, James ... the Adelaide and Meath Hospital and St Patrick’s Hospital ...
... five will be administered anti-polio drops in the national ... for the second consecutive year. ,Kick-starting the 64th ... Dikshit Saturday said the state would continue to remain ... from neighbouring Uttar Pradesh. ,"Not even a ...
... medical graduates really opting to study this field. This pattern ... to the// occasion to bail out the baby boomers, researchers ... month's issue of the Journal of the American Geriatrics Society, ... have said that the number of certified geriatricians in Canada ...
Cached Medicine News:Health News:A young scientist recognized for biomechanics innovations 2Health News:A young scientist recognized for biomechanics innovations 3Health News:1.8 mn Delhi Children to Receive Anti-polio Drops 2
Utrata-like fine angled tips with gently curved shaft for performing capsulorhexis through tunnel incisions. Dull finish. Round handle manufactured in titanium....
Delicate 45 degrees angled shafts and Arruga style tips provide a firm purchase on the lens capsule. Round handle with dull finish....
This cross action forcep has delicate tips for grasping the capsule. The forcep has an iris stop to prevent inadvertent grasping of the iris....
Fine angled 12 mm shafts and iris stop. Round handle for fingertip rotational control. Dull finish....
Medicine Products: